Raymond James Financial’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.04M	Buy	65,214 +1,829	+3%	+$57.2K	﹤0.01%	3062
2025 Q1	$2.13M	Buy	63,385 +43,054	+212%	+$1.44M	﹤0.01%	2937
2024 Q4	$797K	Buy	+20,331	New	+$797K	﹤0.01%	3588